Mitochondria–A target for attenuation of astrocyte pathology

Marlene Thorsen Morch, Reza Khorooshi, Joanna Marczynska, Magdalena Dubik, Soeren Nielsen, John Dirk Nieland, Nasrin Asgari, Trevor Owens*

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

2 Downloads (Pure)

Abstrakt

Astrocyte pathology is a feature of neuromyelitis optica spectrum disorder (NMOSD) pathology. Recently mitochondrial dysfunction and metabolic changes were suggested to play a role in NMOSD. To elucidate the role of mitochondrial dysfunction, astrocyte pathology was induced in C57BL/6 J female mice by intracerebral injection of aquaporin-4-immunoglobulin G from an NMOSD patient, together with complement. Etomoxir has been shown to cause mitochondrial dysfunction. Etomoxir was delivered to the central nervous system and resulted in decreased astrocyte pathology. The ameliorating effect was associated with increases in different acylcarnitines and amino acids. This suggests that mitochondria may be a therapeutic target in NMOSD.

OriginalsprogEngelsk
Artikelnummer577657
TidsskriftJournal of Neuroimmunology
Vol/bind358
Antal sider5
ISSN0165-5728
DOI
StatusUdgivet - 15. sep. 2021

Bibliografisk note

Funding Information:
This research was supported by the Danish Multiple Sclerosis Society ; The Lundbeck Foundation (# R198-2015-171 ); Ph.D. stipends from The University of Southern Denmark, Health Sciences Faculty; Warwara Larsens Fond; Bjarne Jensens Fond; Augustinus Foundation; Lægefonden; Dagmar Marshalls Fond and Familien Hede Nielsens Fond.

Publisher Copyright:
© 2021 The Authors

Fingeraftryk

Dyk ned i forskningsemnerne om 'Mitochondria–A target for attenuation of astrocyte pathology'. Sammen danner de et unikt fingeraftryk.

Citationsformater